Background: Streptococcus bovis (S. bovis) bacteremia and infective endocarditis have a well-established association with colorectal cancer (CRC), though the mechanisms underlying this potentially bidirectional relationship remain poorly understood.
Case summary: This case report describes a 55-year-old male with a history of hypertension and hemicolectomy due to advanced colorectal adenomas who presented with syncope, septic shock, and a 12-pound weight loss over 3 weeks. Subsequent blood cultures grew S. bovis, with a transthoracic echocardiogram revealed mobile vegetations on both the aortic and mitral valves. A sessile, non-obstructing cecal adenocarcinoma was also observed on colonoscopy. The patient was started on 6 weeks of intravenous ceftriaxone, followed by surgical repair of both heart valves and a laparoscopic right hemicolectomy.
Conclusion: This presentation underscores how CRC-induced mucosal disruption may predispose to bacterial translocation, resulting in systemic infection and endocarditis.
{"title":"<i>Streptococcus bovis</i> endocarditis secondary to colorectal cancer: A case report.","authors":"Kyle Nguyen-Ngo, Vinit H Majmudar, Aryan Jain, Nihita Manem, Katherine Donovan, Micheal Tadros","doi":"10.12998/wjcc.v14.i3.117276","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117276","url":null,"abstract":"<p><strong>Background: </strong><i>Streptococcus bovis</i> (<i>S. bovis</i>) bacteremia and infective endocarditis have a well-established association with colorectal cancer (CRC), though the mechanisms underlying this potentially bidirectional relationship remain poorly understood.</p><p><strong>Case summary: </strong>This case report describes a 55-year-old male with a history of hypertension and hemicolectomy due to advanced colorectal adenomas who presented with syncope, septic shock, and a 12-pound weight loss over 3 weeks. Subsequent blood cultures grew <i>S. bovis</i>, with a transthoracic echocardiogram revealed mobile vegetations on both the aortic and mitral valves. A sessile, non-obstructing cecal adenocarcinoma was also observed on colonoscopy. The patient was started on 6 weeks of intravenous ceftriaxone, followed by surgical repair of both heart valves and a laparoscopic right hemicolectomy.</p><p><strong>Conclusion: </strong>This presentation underscores how CRC-induced mucosal disruption may predispose to bacterial translocation, resulting in systemic infection and endocarditis.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117276"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.113275
Shu-Ting Mei, Lu Li, Jie-Jing Li
Background: The management of stage IV pressure ulcers (PUs) in elderly, high-risk surgical patients remains a formidable clinical challenge, often limited by the invasiveness and risks of standard surgical options. Although Aloe vera has known wound-healing properties, clinical evidence of its efficacy in complex, severe PUs is scarce. This case report details a novel, non-invasive combination therapy centered around an aloe-derived micellar emulsion dressing (Aloe vera barbadensis extract R, AVBER) and demonstrates its potential as a viable palliative strategy for this vulnerable population.
Case summary: A 90-year-old, severely malnourished female (body mass index 13.3 kg/m2) presented with extensive, bilateral stage IV ischial PUs following a femoral fracture. Given her frailty and high surgical risk, a conservative regimen was initiated. This regimen comprised the topical application of an AVBER dressing, targeted red light therapy, and intensive nutritional support, all guided through telemedicine. Over a period of 8.5 months, this treatment was associated with complete healing of the left ulcer and near-complete resolution (from 15 cm × 15 cm to 0.8 cm × 3.0 cm) of the right ulcer, with no serious adverse events reported. The PU scale for healing score for the right ischial ulcer decreased markedly from 17 to 6.
Conclusion: AVBER-based combination therapy represents a promising non-invasive option for managing severe PUs in surgically ineligible patients.
背景:老年人高风险手术患者IV期压疮(PUs)的处理仍然是一个巨大的临床挑战,通常受到标准手术选择的侵入性和风险的限制。虽然芦荟具有已知的伤口愈合特性,但临床证据表明其对复杂,严重脓液的疗效很少。本病例报告详细介绍了一种以芦荟胶束乳液敷料(芦荟提取物R, AVBER)为中心的新型非侵入性联合治疗,并展示了其作为这一弱势群体可行的姑息策略的潜力。病例总结:一名90岁,严重营养不良的女性(体重指数13.3 kg/m2),在股骨骨折后出现广泛的双侧IV期坐骨脓液。鉴于她身体虚弱,手术风险高,我们开始了保守治疗。该方案包括局部应用AVBER敷料,靶向红光治疗和强化营养支持,所有这些都通过远程医疗指导。在8.5个月的时间里,这种治疗与左侧溃疡完全愈合和右侧溃疡几乎完全消退(从15cm × 15cm到0.8 cm × 3.0 cm)相关,没有严重的不良事件报告。右侧坐骨溃疡愈合评分PU由17分明显下降至6分。结论:以avber为基础的联合治疗是治疗不符合手术条件的严重脓毒症患者的一种有希望的非侵入性选择。
{"title":"Aloe-derived micellar emulsion dressing combination therapy for pressure ulcers: A case report and review of literature.","authors":"Shu-Ting Mei, Lu Li, Jie-Jing Li","doi":"10.12998/wjcc.v14.i3.113275","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.113275","url":null,"abstract":"<p><strong>Background: </strong>The management of stage IV pressure ulcers (PUs) in elderly, high-risk surgical patients remains a formidable clinical challenge, often limited by the invasiveness and risks of standard surgical options. Although <i>Aloe vera</i> has known wound-healing properties, clinical evidence of its efficacy in complex, severe PUs is scarce. This case report details a novel, non-invasive combination therapy centered around an aloe-derived micellar emulsion dressing (<i>Aloe vera barbadensis</i> extract R, AVBER) and demonstrates its potential as a viable palliative strategy for this vulnerable population.</p><p><strong>Case summary: </strong>A 90-year-old, severely malnourished female (body mass index 13.3 kg/m<sup>2</sup>) presented with extensive, bilateral stage IV ischial PUs following a femoral fracture. Given her frailty and high surgical risk, a conservative regimen was initiated. This regimen comprised the topical application of an AVBER dressing, targeted red light therapy, and intensive nutritional support, all guided through telemedicine. Over a period of 8.5 months, this treatment was associated with complete healing of the left ulcer and near-complete resolution (from 15 cm × 15 cm to 0.8 cm × 3.0 cm) of the right ulcer, with no serious adverse events reported. The PU scale for healing score for the right ischial ulcer decreased markedly from 17 to 6.</p><p><strong>Conclusion: </strong>AVBER-based combination therapy represents a promising non-invasive option for managing severe PUs in surgically ineligible patients.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"113275"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.116125
Zhi-Dong Jia, Cheng-Yan Zhang, Sheng-Zhi Liang, Hai-Liang Li
Background: Histiocytic sarcoma (HS) is a rare lymphohematopoietic malignancy with nonspecific clinical manifestations, diagnostic challenges, high aggressiveness, and a poor prognosis. Primary HSs arising in the spleen are extremely uncommon, with few cases reported globally. Here, we present the clinical course of a patient with splenic HS.
Case summary: A 67-year-old woman was admitted to our hospital because of a large splenic mass that was detected during a routine health examination 1 month before presentation. Abdominal computed tomography revealed a large occupying lesion in the spleen, which was possibly a lymphangioma. The patient underwent splenectomy, and postoperative pathological examination confirmed the diagnosis of splenic HS. At the 6-month telephonic follow-up, the patient reported feeling well.
Conclusion: Given the paucity of cases and the poor prognosis of splenic HS, whose definitive diagnosis hinges exclusively on pathology, and given that all current therapeutic strategies are based on isolated case reports, it is imperative to enhance our understanding of this disease to improve patient diagnosis and management.
{"title":"Primary splenic histiocytic sarcoma: A case report and review of literature.","authors":"Zhi-Dong Jia, Cheng-Yan Zhang, Sheng-Zhi Liang, Hai-Liang Li","doi":"10.12998/wjcc.v14.i3.116125","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.116125","url":null,"abstract":"<p><strong>Background: </strong>Histiocytic sarcoma (HS) is a rare lymphohematopoietic malignancy with nonspecific clinical manifestations, diagnostic challenges, high aggressiveness, and a poor prognosis. Primary HSs arising in the spleen are extremely uncommon, with few cases reported globally. Here, we present the clinical course of a patient with splenic HS.</p><p><strong>Case summary: </strong>A 67-year-old woman was admitted to our hospital because of a large splenic mass that was detected during a routine health examination 1 month before presentation. Abdominal computed tomography revealed a large occupying lesion in the spleen, which was possibly a lymphangioma. The patient underwent splenectomy, and postoperative pathological examination confirmed the diagnosis of splenic HS. At the 6-month telephonic follow-up, the patient reported feeling well.</p><p><strong>Conclusion: </strong>Given the paucity of cases and the poor prognosis of splenic HS, whose definitive diagnosis hinges exclusively on pathology, and given that all current therapeutic strategies are based on isolated case reports, it is imperative to enhance our understanding of this disease to improve patient diagnosis and management.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"116125"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.114521
Pratap Rudra Mahanty, Biswajit Sen, Rishi Anand, Deb Sanjay Nag, Nirakar Pahadi, Dona Lodh, Tinali Upadhyaya
Background: Postdural puncture headache (PDPH) is a significant complication of neuraxial procedures. Although conservative treatments and the invasive epidural blood patch (EBP) are currently standard approaches, the sphenopalatine ganglion (SPG) block is emerging as a promising, less-invasive alternative. The pathophysiology of PDPH involves cerebrospinal fluid leakage, resulting in reduced intracranial pressure and compensatory cerebral vasodilation, which is partially mediated by SPG stimulation. The SPG block aims to interrupt this vasodilation using local anesthetics, thereby alleviating headache symptoms.
Aim: To provide a comprehensive overview of current evidence regarding the use of the SPG block in treating PDPH, explores the anatomical and physiological basis of this intervention, describes various administration techniques for administering the block, and critically assesses the efficacy and safety data from clinical studies.
Methods: A systematic literature search was conducted on PubMed and the Cochrane Database to identify systematic reviews and meta-analyses published up to April 2025, using the keywords "sphenopalatine ganglion block" and "post-dural puncture headache".
Results: The SPG block is a simple, noninvasive, and effective bedside procedure. Clinical studies have demonstrated that it provides rapid pain relief, with high success rates and an onset of action typically within 10-30 minutes. The most used technique is the transnasal approach, which is associated with minimal and transient adverse effects such as nasal discomfort and bitter taste.
Conclusion: Although EBP remains the preferred treatment for severe PDPH, the SPG block is a viable alternative for mild-to-moderate cases, often allowing patients to postpone or avoid EBP. Comparative studies suggest that SPG block has a quicker onset than EBP, though in some cases, it provides shorter duration relief. Overall, the SPG block is a safe, effective, and readily accessible treatment for PDPH. Its minimally invasive nature and high success rate in providing rapid pain relief make it an excellent first-line alternative to more invasive procedures. Further large-scale, standardized randomized controlled trials are required to optimize protocols and fully integrate the SPG block into mainstream clinical practice.
{"title":"Sphenopalatine ganglion block for postdural puncture headache: A review of current evidence.","authors":"Pratap Rudra Mahanty, Biswajit Sen, Rishi Anand, Deb Sanjay Nag, Nirakar Pahadi, Dona Lodh, Tinali Upadhyaya","doi":"10.12998/wjcc.v14.i3.114521","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.114521","url":null,"abstract":"<p><strong>Background: </strong>Postdural puncture headache (PDPH) is a significant complication of neuraxial procedures. Although conservative treatments and the invasive epidural blood patch (EBP) are currently standard approaches, the sphenopalatine ganglion (SPG) block is emerging as a promising, less-invasive alternative. The pathophysiology of PDPH involves cerebrospinal fluid leakage, resulting in reduced intracranial pressure and compensatory cerebral vasodilation, which is partially mediated by SPG stimulation. The SPG block aims to interrupt this vasodilation using local anesthetics, thereby alleviating headache symptoms.</p><p><strong>Aim: </strong>To provide a comprehensive overview of current evidence regarding the use of the SPG block in treating PDPH, explores the anatomical and physiological basis of this intervention, describes various administration techniques for administering the block, and critically assesses the efficacy and safety data from clinical studies<b>.</b></p><p><strong>Methods: </strong>A systematic literature search was conducted on PubMed and the Cochrane Database to identify systematic reviews and meta-analyses published up to April 2025, using the keywords \"sphenopalatine ganglion block\" and \"post-dural puncture headache\".</p><p><strong>Results: </strong>The SPG block is a simple, noninvasive, and effective bedside procedure. Clinical studies have demonstrated that it provides rapid pain relief, with high success rates and an onset of action typically within 10-30 minutes. The most used technique is the transnasal approach, which is associated with minimal and transient adverse effects such as nasal discomfort and bitter taste.</p><p><strong>Conclusion: </strong>Although EBP remains the preferred treatment for severe PDPH, the SPG block is a viable alternative for mild-to-moderate cases, often allowing patients to postpone or avoid EBP. Comparative studies suggest that SPG block has a quicker onset than EBP, though in some cases, it provides shorter duration relief. Overall, the SPG block is a safe, effective, and readily accessible treatment for PDPH. Its minimally invasive nature and high success rate in providing rapid pain relief make it an excellent first-line alternative to more invasive procedures. Further large-scale, standardized randomized controlled trials are required to optimize protocols and fully integrate the SPG block into mainstream clinical practice.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"114521"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.114691
Hong Wang, Shi-Liang Wang, Chen-Jie Ge, Li-Lei Lei, Lei Zeng, Min-Cai Qian
<p><strong>Background: </strong>Anxiety disorders are highly prevalent in patients with bipolar disorder (BD) and are associated with a more severe illness course and poorer outcomes. A significant clinical challenge is the frequent initial misdiagnosis of BD as anxiety, leading to prolonged diagnostic delays and suboptimal treatment. Growing evidence suggests that early intervention in individuals at high risk for BD can improve prognosis. Established clinical high-risk factors include early onset, family history of BD, and subthreshold manic symptoms. This creates a clinical dilemma whereby the administration of first-line antidepressants (<i>e.g.</i>, sertraline) for anxiety is debated in patients with a bipolar diathesis, given the associated risk of mood destabilization. Conversely, mood stabilizers like lithium are foundational in BD treatment, but their role in treating anxiety in high-risk populations is unproven. Therefore, we conducted this randomized controlled trial to evaluate whether early intervention with a combination of sertraline and lithium is more effective than sertraline monotherapy for anxiety disorder patients with clinical high-risk factors for BD.</p><p><strong>Aim: </strong>To investigate whether early intervention has a more positive outcome for anxiety disorders in patients who present with clinical high risk factors for BD.</p><p><strong>Methods: </strong>A total of 66 patients were enrolled in this study from January 2021 and December 2022 in Huzhou Third Municipal Hospital. They were randomly assigned to two groups to receive either an antidepressant (sertraline, <i>n</i> = 32) or a combination therapy (sertraline and lithium, <i>n</i> = 34). The main variables included alterations in Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores from the initial assessment to the final evaluation. A thorough combined Wald test was conducted to examine the intention-to-treat differences in scale assessment across treatment and time conditions.</p><p><strong>Results: </strong>Significant differences in the change of Hamilton Anxiety Rating Scale scores were observed between the two groups at week 1, week 2, and week 4 (<i>P</i> < 0.05). However, after 8 weeks and 12 weeks of treatment, there were no significant different (<i>P</i> = 0.485 and <i>P</i> = 0.206). There was no significant difference in the change over time in Hamilton Depression Rating Scale scores between the treatment groups (<i>P</i> = 0.2), except at week 12 (<i>P</i> = 0.034). No significant differences were observed in the adverse effects reported between patients treated with sertraline alone (18%) and those treated with the combination therapy (21%).</p><p><strong>Conclusion: </strong>This current double-blind, case-controlled study assessed the effectiveness and tolerability of combined therapy <i>vs</i> monotherapy for anxiety disorder in patients with clinical high-risk factors for BD. In light of the constraints associated with
{"title":"Early intervention in anxiety disorder patients with clinical high-risk factors for bipolar disorder: A randomized controlled trial.","authors":"Hong Wang, Shi-Liang Wang, Chen-Jie Ge, Li-Lei Lei, Lei Zeng, Min-Cai Qian","doi":"10.12998/wjcc.v14.i3.114691","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.114691","url":null,"abstract":"<p><strong>Background: </strong>Anxiety disorders are highly prevalent in patients with bipolar disorder (BD) and are associated with a more severe illness course and poorer outcomes. A significant clinical challenge is the frequent initial misdiagnosis of BD as anxiety, leading to prolonged diagnostic delays and suboptimal treatment. Growing evidence suggests that early intervention in individuals at high risk for BD can improve prognosis. Established clinical high-risk factors include early onset, family history of BD, and subthreshold manic symptoms. This creates a clinical dilemma whereby the administration of first-line antidepressants (<i>e.g.</i>, sertraline) for anxiety is debated in patients with a bipolar diathesis, given the associated risk of mood destabilization. Conversely, mood stabilizers like lithium are foundational in BD treatment, but their role in treating anxiety in high-risk populations is unproven. Therefore, we conducted this randomized controlled trial to evaluate whether early intervention with a combination of sertraline and lithium is more effective than sertraline monotherapy for anxiety disorder patients with clinical high-risk factors for BD.</p><p><strong>Aim: </strong>To investigate whether early intervention has a more positive outcome for anxiety disorders in patients who present with clinical high risk factors for BD.</p><p><strong>Methods: </strong>A total of 66 patients were enrolled in this study from January 2021 and December 2022 in Huzhou Third Municipal Hospital. They were randomly assigned to two groups to receive either an antidepressant (sertraline, <i>n</i> = 32) or a combination therapy (sertraline and lithium, <i>n</i> = 34). The main variables included alterations in Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores from the initial assessment to the final evaluation. A thorough combined Wald test was conducted to examine the intention-to-treat differences in scale assessment across treatment and time conditions.</p><p><strong>Results: </strong>Significant differences in the change of Hamilton Anxiety Rating Scale scores were observed between the two groups at week 1, week 2, and week 4 (<i>P</i> < 0.05). However, after 8 weeks and 12 weeks of treatment, there were no significant different (<i>P</i> = 0.485 and <i>P</i> = 0.206). There was no significant difference in the change over time in Hamilton Depression Rating Scale scores between the treatment groups (<i>P</i> = 0.2), except at week 12 (<i>P</i> = 0.034). No significant differences were observed in the adverse effects reported between patients treated with sertraline alone (18%) and those treated with the combination therapy (21%).</p><p><strong>Conclusion: </strong>This current double-blind, case-controlled study assessed the effectiveness and tolerability of combined therapy <i>vs</i> monotherapy for anxiety disorder in patients with clinical high-risk factors for BD. In light of the constraints associated with ","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"114691"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.117165
Ahmed Mostafa Sira, Samar Ahmed Shoeir, Mostafa Mohamed Sira
Background: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease, characterized by uncontrolled activation of the innate immune system that manifests as recurrent fever and polyserositis (e.g., peritonitis, pleuritis, and arthritis). However, diagnosing atypical cases remains challenging.
Case summary: A 9-year-old girl had a history of progressive loss of appetite, weight loss, and myalgia over the preceding three months. She developed high-grade fever over the preceding three weeks, occasionally associated with abdominal pain. The girl is one of a triplet; neither of the other two sisters had similar symptoms. Family history was irrelevant. She presented with cachexia, generalized body aches, and fever without evident arthritis. She had splenomegaly and a markedly elevated erythrocyte sedimentation rate. After exclusion of rheumatological and malignant causes, FMF was suspected. Serum amyloid A was high. The patient received colchicine therapy. There was a significant improvement in her symptoms with normalization of acute-phase reactants. Polymerase chain reaction test for FMF gene mutation returned negative.
Conclusion: FMF can present with atypical symptoms. Detailed history and meticulous clinical evaluation were key clues suggesting the diagnosis.
{"title":"Cachexia as an unusual presentation of familial Mediterranean fever: A case report.","authors":"Ahmed Mostafa Sira, Samar Ahmed Shoeir, Mostafa Mohamed Sira","doi":"10.12998/wjcc.v14.i3.117165","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117165","url":null,"abstract":"<p><strong>Background: </strong>Familial Mediterranean fever (FMF) is the most common autoinflammatory disease, characterized by uncontrolled activation of the innate immune system that manifests as recurrent fever and polyserositis (<i>e.g.</i>, peritonitis, pleuritis, and arthritis). However, diagnosing atypical cases remains challenging.</p><p><strong>Case summary: </strong>A 9-year-old girl had a history of progressive loss of appetite, weight loss, and myalgia over the preceding three months. She developed high-grade fever over the preceding three weeks, occasionally associated with abdominal pain. The girl is one of a triplet; neither of the other two sisters had similar symptoms. Family history was irrelevant. She presented with cachexia, generalized body aches, and fever without evident arthritis. She had splenomegaly and a markedly elevated erythrocyte sedimentation rate. After exclusion of rheumatological and malignant causes, FMF was suspected. Serum amyloid A was high. The patient received colchicine therapy. There was a significant improvement in her symptoms with normalization of acute-phase reactants. Polymerase chain reaction test for <i>FMF</i> gene mutation returned negative.</p><p><strong>Conclusion: </strong>FMF can present with atypical symptoms. Detailed history and meticulous clinical evaluation were key clues suggesting the diagnosis.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117165"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.
长期暴露于微重力环境对眼部生理产生深远影响,导致与航天飞行相关的神经-眼综合征,这是执行长期任务的宇航员所关心的一个重大问题。这篇综述整合了目前关于眼部适应太空飞行的证据,包括病理生理机制、诊断进展、相关眼部疾病和新出现的对策。2000年至2025年间发表的文献在PubMed、Scopus和Web of Science上进行了系统的检查,整合了同行评审的研究和来自美国国家航空航天局和欧洲航天局的技术报告。调查结果表明,与SANS相符的眼部变化影响了大约三分之一的宇航员,在超过六个月的任务期间患病率更高。标志性特征包括视盘水肿、后球变平和轻度远视移位,这是由头液移位、脑脊液动力学改变、静脉充血和淋巴血流受损引起的。除了SANS,微重力还会使宇航员容易患上干眼病、免疫相关感染和辐射诱发的白内障。最近在飞行光学相干断层扫描、光学相干断层扫描血管造影和超声方面的进展增强了早期检测,而下体负压、人工重力和人工智能驱动的眼监测等对策也有希望。了解眼部对空间的适应不仅可以减轻任务风险,还可以丰富地面上对颅内压调节和神经眼健康的认识。
{"title":"Ocular health in outer space and beyond gravity: A minireview.","authors":"Srishti Khullar, Arvind Kumar Morya, Sarita Aggarwal, Twinkle Gupta, Priyanka Priyanka, Rannusha Morya","doi":"10.12998/wjcc.v14.i3.117257","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117257","url":null,"abstract":"<p><p>Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117257"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12835991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.12998/wjcc.v14.i3.117076
Shree V Dhotre, Pradnya S Dhotre, Ajay M Gavkare, Basavraj S Nagoba
The recently published case report describing mixed connective tissue disease coexisting with tuberculosis (TB) provides an important contribution to the growing literature on complex autoimmune-infectious disease interactions. This letter expands on the diagnostic challenges highlighted by the authors by defining its added clinical value: Identifying practical diagnostic "red flags", emphasizing parallel consideration of autoimmunity and infection, and proposing a pragmatic approach to evaluation in TB-endemic settings. Early immunological testing, differentiated pulmonary assessment, and multidisciplinary decision-making are essential when overlapping features obscure timely diagnosis and complicate therapeutic choices.
{"title":"Diagnostic perspectives on mixed connective tissue disease with tuberculosis overlap.","authors":"Shree V Dhotre, Pradnya S Dhotre, Ajay M Gavkare, Basavraj S Nagoba","doi":"10.12998/wjcc.v14.i3.117076","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117076","url":null,"abstract":"<p><p>The recently published case report describing mixed connective tissue disease coexisting with tuberculosis (TB) provides an important contribution to the growing literature on complex autoimmune-infectious disease interactions. This letter expands on the diagnostic challenges highlighted by the authors by defining its added clinical value: Identifying practical diagnostic \"red flags\", emphasizing parallel consideration of autoimmunity and infection, and proposing a pragmatic approach to evaluation in TB-endemic settings. Early immunological testing, differentiated pulmonary assessment, and multidisciplinary decision-making are essential when overlapping features obscure timely diagnosis and complicate therapeutic choices.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117076"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.12998/wjcc.v14.i2.116700
Arunkumar Krishnan, Kaleb Lucas, Laura Maas, Tinsay A Woreta
Background: Drug-induced liver injury poses a diagnostic challenge in oncology patients, especially those on immune checkpoint inhibitors, because symptoms often overlap with immune-mediated hepatitis. The increasing use of social media has led people to self-administer veterinary anthelmintics like fenbendazole for cancer, often at high doses and without medical guidance, despite limited data on safety or effectiveness.
Case summary: We report a case of a 47-year-old woman with metastatic colon cancer on nivolumab/relatlimab who developed severe hepatocellular liver injury after increasing her self-administered dose of fenbendazole. A detailed medical and temporal history, supported by a Roussel Uclaf Causality Assessment Method score of 8 (probable), identified fenbendazole as the most likely cause. Rapid biochemical improvement occurred after stopping the drug, with safe reintroduction of immunotherapy and no recurrence of liver injury.
Conclusion: This case emphasizes the importance of thorough medication history-taking and structured causality assessment to distinguish between unregulated drug-induced liver injury and immune-related adverse events in cancer care. The use of social media to promote alternative therapies necessitates proactive patient counseling due to significant liver risks, and careful diagnostic evaluation can prevent unnecessary immunosuppression or treatment delays.
{"title":"Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report.","authors":"Arunkumar Krishnan, Kaleb Lucas, Laura Maas, Tinsay A Woreta","doi":"10.12998/wjcc.v14.i2.116700","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i2.116700","url":null,"abstract":"<p><strong>Background: </strong>Drug-induced liver injury poses a diagnostic challenge in oncology patients, especially those on immune checkpoint inhibitors, because symptoms often overlap with immune-mediated hepatitis. The increasing use of social media has led people to self-administer veterinary anthelmintics like fenbendazole for cancer, often at high doses and without medical guidance, despite limited data on safety or effectiveness.</p><p><strong>Case summary: </strong>We report a case of a 47-year-old woman with metastatic colon cancer on nivolumab/relatlimab who developed severe hepatocellular liver injury after increasing her self-administered dose of fenbendazole. A detailed medical and temporal history, supported by a Roussel Uclaf Causality Assessment Method score of 8 (probable), identified fenbendazole as the most likely cause. Rapid biochemical improvement occurred after stopping the drug, with safe reintroduction of immunotherapy and no recurrence of liver injury.</p><p><strong>Conclusion: </strong>This case emphasizes the importance of thorough medication history-taking and structured causality assessment to distinguish between unregulated drug-induced liver injury and immune-related adverse events in cancer care. The use of social media to promote alternative therapies necessitates proactive patient counseling due to significant liver risks, and careful diagnostic evaluation can prevent unnecessary immunosuppression or treatment delays.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 2","pages":"116700"},"PeriodicalIF":1.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Oral cavity cancers are highly invasive malignancies, typically treated with a combination of surgery, radiation, and chemotherapy. Surgical intervention requires the removal of all affected tissues, including the mandibular basal bone. Reconstructive procedures may involve tissue and skin grafts, such as fibula free flaps in the case of mandibulectomy. These techniques aim to minimize scarring and restore basic oral functions. However, radiation therapy may result in fibrotic scarring of the connective tissues. This case report focuses on the integration of surgical, prosthetic, and complementary therapies - including hyaluronic acid (HA) -based filler - to address both functional and aesthetic deficiencies.
Case summary: The case involves a 70-year-old woman who underwent a right segmental mandibulectomy with fibula free flap reconstruction for pT4aN2b oral squamous cell carcinoma, followed by adjuvant radiochemotherapy. After surgery, she presented to the Odontology Department of Montpellier University Hospital with severe trismus, impaired mastication, and aesthetic concerns, including marked facial atrophy and asymmetry of the face and mouth. The multidisciplinary approach included fluoride trays to address radiotherapy-induced risks, caries treatment, a mandibular partial removable prosthesis for occlusal and soft tissue support, occlusal bonding, and HA injections to restore facial symmetry and improve soft tissue quality. HA was injected into the fibrotic connective tissue to improve skin hydration and counterbalance the asymmetry of the mouth. The combination of prosthetic rehabilitation and HA injections led to significant functional and aesthetic improvements, with a notable positive impact on the patient's sociability and quality of life.
Conclusion: This case highlights how a multidisciplinary, comprehensive, personalized, and biopsychosocial approach can optimize outcomes in complex oral rehabilitation following oncological surgery.
{"title":"Functional and aesthetic oral rehabilitation after cancer treatment using dental prosthesis and hyaluronic acid injections: A case report and review of literature.","authors":"Nadège Hessloehl, Pierre-Yves Collart-Dutilleul, Olivier Romieu, Delphine Carayon","doi":"10.12998/wjcc.v14.i2.110627","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i2.110627","url":null,"abstract":"<p><strong>Background: </strong>Oral cavity cancers are highly invasive malignancies, typically treated with a combination of surgery, radiation, and chemotherapy. Surgical intervention requires the removal of all affected tissues, including the mandibular basal bone. Reconstructive procedures may involve tissue and skin grafts, such as fibula free flaps in the case of mandibulectomy. These techniques aim to minimize scarring and restore basic oral functions. However, radiation therapy may result in fibrotic scarring of the connective tissues. This case report focuses on the integration of surgical, prosthetic, and complementary therapies - including hyaluronic acid (HA) -based filler - to address both functional and aesthetic deficiencies.</p><p><strong>Case summary: </strong>The case involves a 70-year-old woman who underwent a right segmental mandibulectomy with fibula free flap reconstruction for pT4aN2b oral squamous cell carcinoma, followed by adjuvant radiochemotherapy. After surgery, she presented to the Odontology Department of Montpellier University Hospital with severe trismus, impaired mastication, and aesthetic concerns, including marked facial atrophy and asymmetry of the face and mouth. The multidisciplinary approach included fluoride trays to address radiotherapy-induced risks, caries treatment, a mandibular partial removable prosthesis for occlusal and soft tissue support, occlusal bonding, and HA injections to restore facial symmetry and improve soft tissue quality. HA was injected into the fibrotic connective tissue to improve skin hydration and counterbalance the asymmetry of the mouth. The combination of prosthetic rehabilitation and HA injections led to significant functional and aesthetic improvements, with a notable positive impact on the patient's sociability and quality of life.</p><p><strong>Conclusion: </strong>This case highlights how a multidisciplinary, comprehensive, personalized, and biopsychosocial approach can optimize outcomes in complex oral rehabilitation following oncological surgery.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 2","pages":"110627"},"PeriodicalIF":1.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}